DaviesL, WelchHG. 2006. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA, 295:2164–2167.
2.
AhnHS, KimHJ, WelchHG. 2014. Korea's thyroid-cancer “epidemic”—screening and overdiagnosis. N Engl J Med, 371:1765–1767.
3.
HayID. 2006. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol, 94:692–700.
4.
HaugenBR, AlexanderEK, BibleKC, DohertyGM, MandelSJ, NikiforovYE, PaciniF, RandolphGW, SawkaAM, SchlumbergerM, SchuffKG, ShermanSI, SosaJA, StewardDL, TuttleRM, WartofskyL. 2016. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26:1–133.
RamseyS, BloughD, KirchhoffA, KreizenbeckK, FedorenkoC, SnellK, NewcombP, HollingworthW, OverstreetK. 2013. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood), 32:1143–1152.
7.
EssermanLJ, ThompsonIM, ReidB, NelsonP, RansohoffDF, WelchHG, HwangS, BerryDA, KinzlerKW, BlackWC, BissellM, ParnesH, SrivastavaS. 2014. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol, 15:e234–242.
8.
NikiforovYE, SeethalaRR, TalliniG, BalochZW, BasoloF, ThompsonIM, BarlettaJA, WenigBM, GhuzlanAA, KakudoK, GiordanoTJ, AlvesVA, KhanafsharE, AsaSL, El-NaggarA, GoodingWE, HodakSP, LloydRV, MaytalG, MeteO, Nikiforova, NoséV, PapottiM, PollerDN, SadowPM, TischlerAS, TuttleRM, WallKB, LiVolsiVA, RandolphGW, GhosseinRA. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol, 2016Apr14. DOI: 10.1001/jamaoncol.2016.0386. [Epub ahead of print].
9.
JungCK, LittleMP, LubinJH, BrennerAV, WellsSAJr, SigurdsonAJ, NikiforovYE. 2014. The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J Clin Endocrinol Metab, 99:E276–285.
10.
LupiC, GianniniR, UgoliniC, ProiettiA, BertiP, MinutoM, MaterazziG, EliseiR, SantoroM, MiccoliP, BasoloF. 2007. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab, 92:4085–4090.
11.
GanlyI, WangL, TuttleRM, KatabiN, CeballosGA, HarachHR, GhosseinR. 2015. Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant. Hum Pathol, 46:657–664.
12.
RosarioPW, PennaGC, CalsolariMR. 2014. Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: is lobectomy sufficient for tumours ≥1 cm?. Clin Endocrinol (Oxf), 81:630–632.
13.
PianaS, FrasoldatiA, Di FeliceE, GardiniG, TalliniG, RosaiJ. 2010. Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol, 34:868–872.
14.
ViveroM, KraftS, BarlettaJA. 2013. Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid, 23:273–279.
15.
BalochZW, LiVolsiVA. 2000. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol, 13:861–865.
16.
HowittBE, PaulsonVA, BarlettaJA. 2015. Absence of BRAF V600E in non-infiltrative, non-invasive follicular variant of papillary thyroid carcinoma. Histopathology, 67:579–582.
17.
LiuZ, ZhouG, NakamuraM, KoikeE, LiY, OzakiT, MoriI, TaniguchiE, KakudoK. 2011. Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal. Cancer Sci, 102:288–294.
18.
SontagS. 1978. Illness as Metaphor. Farrar, Straus and Giroux, New York.
19.
American Cancer Society. 2014. Coping with cancer in everyday life. The emotional impact of a cancer diagnosis. Available at: www.cancer.org/treatment/treatmentsandsideeffects/emotionalsideeffects/copingwithcancerineverydaylife/a-message-of-hope-emotional-impact-of-cancer (accessed June2014).
20.
HauchA, Al-QurayshiZ, RandolphG, KandilE. 2014. Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons. Ann Surg Oncol, 21:3844–3852.
21.
IyerNG, MorrisLG, TuttleRM, ShahaAR, GanlyI. 2011. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer, 117:4439–4446.
